ArticleCancer medicine2022

First-line PD-1/PD-L1 inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non-squamous non-small cell lung cancer: A Bayesian network meta-analysis of randomized controlled trials.

Jinzhao Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.